Key Releases are ad hoc announcements pursuant to SIX Swiss Exchange Article 53 Listing Rules.
Header
News archive
News Archive Navigation
icon
News Archive Navigation Language
Language Preferences
Showing 1793 results
June 2016
-
In The NewsPerfecting access through embedded sustainability, pooling resources and consolidating expertiseA guest blog post from Anthony Gitau, Country Head of Novartis Access and Familia Nawiri in Kenya.
-
Media ReleaseNovartis PKC412 (midostaurin) pivotal data published in NEJM show 60% response rate in advanced systemic mastocytosis (SM)In the largest and longest-running prospective trial in advanced SM, 60% of patients achieved complete or partial resolution of organ damage[1] Advanced SM is rare and has a poor prognosis[…
-
Molecular glue kills cancer cells in mice
Compounds block a protein involved in many cancers by cementing it shut.
-
Media ReleaseLargest global psoriasis survey shows 84% of people face discrimination and humiliation because of their skinGlobal survey of over 8,300 people with moderate-to-severe psoriasis is the first to look at perceptions of clear skin[1] Nearly half (45%) have been asked if they are contagious while 55% do not…
-
Media ReleaseNovartis adds bispecific antibodies to its growing immuno-oncology portfolio through collaboration and licensing agreement with XencorAgreement is the latest in a series of acquisitions and strategic collaborations that have bolstered Novartis' deep and diverse immuno-oncology pipeline Collaboration will co-develop Xencor's…
-
Tuning drugs to succeed on the cell’s surface
Researchers improve our understanding about how compounds bind to proteins in the cell membrane—and the membrane itself.
-
Media ReleaseTimely use of Novartis' Entresto could prevent or postpone over 28,000 US deaths per year among HFrEF patients, according to an expert analysis in JAMA CardiologyFindings are first to quantify magnitude of potential survival benefits if Entresto were prescribed to all eligible US HFrEF patients (as defined by authors) [1] Cardiology experts…
-
In The NewsExpanding access to healthcare: What will it really take?Head of global nonprofit PATH explores how “social innovation” such as the Novartis Access program is helping expand access to healthcare in some of the world’s poorest countries.
-
In The NewsMalaria's deadly comebackIn an editorial for Project Syndicate, Nick White, Professor of Tropical Medicine at the Mahidol Oxford Tropical Medicine Research Unit in Bangkok, and Thierry Diagana, Head of the Novartis Institute…
-
Tackling the common denominator in liver disease
Researchers focus on reversing the scarring that’s common to liver diseases.
-
Migraine: One of the world’s most common diseases
Did you know migraine is the most common of all neurological disorders? Learn more surprising facts.
Pagination
- ‹ Previous page
- 1
- …
- 121
- 122
- 123
- 124
- 125
- 126
- 127
- …
- 150
- › Next page